APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Penicillin & Streptomycin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Penicillin & Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchPenicillin & Streptomycin Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin & Streptomycin Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Penicillin & Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin & Streptomycin Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin & Streptomycin Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Penicillin & Streptomycin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Penicillin & Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Penicillin & Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin & Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Penicillin & Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Penicillin & Streptomycin include Takeda Pharmaceutical Company, Johnson & Johnson, Novartis, Merck & Co., Roche Pharmaceuticals, Eli Lilly and Co, Pfizer, GlaxoSmithKline and Bayer HealthCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Penicillin & Streptomycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Penicillin & Streptomycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Penicillin & Streptomycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Penicillin & Streptomycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Penicillin & Streptomycin Segment by Company

Takeda Pharmaceutical Company

Johnson & Johnson

Novartis

Merck & Co.

Roche Pharmaceuticals

Eli Lilly and Co

Pfizer

GlaxoSmithKline

Bayer HealthCare

Amgen

Astra Zeneca

Toyama Chemical

Sanofi Aventis

MiddleBrook Pharmaceuticals

Gilead Sciences

Celgine Corporation

Bristol Myers Squibb

Biogen IDEC

Astellas Pharma

Abbot Laboratories

Penicillin & Streptomycin Segment by Type

Penicillin

Streptomycin

Penicillin & Streptomycin Segment by Application

Hospitals

Clinics

Others

Penicillin & Streptomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin & Streptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin & Streptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin & Streptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Penicillin & Streptomycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Penicillin & Streptomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Penicillin & Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Penicillin & Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Penicillin & Streptomycin Industry Trends Table 2. Penicillin & Streptomycin Industry Drivers Table 3. Penicillin & Streptomycin Industry Opportunities and Challenges Table 4. Penicillin & Streptomycin Industry Restraints Table 5. Global Penicillin & Streptomycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Penicillin & Streptomycin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Penicillin & Streptomycin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Penicillin & Streptomycin Sales Market Share by Manufacturers Table 9. Global Penicillin & Streptomycin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Penicillin & Streptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Penicillin & Streptomycin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Penicillin & Streptomycin Manufacturers, Product Type & Application Table 13. Global Penicillin & Streptomycin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Penicillin & Streptomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Penicillin Table 17. Major Manufacturers of Streptomycin Table 18. Global Penicillin & Streptomycin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Penicillin & Streptomycin Sales by Type (2021-2026) & (k units) Table 20. Global Penicillin & Streptomycin Sales by Type (2027-2032) & (k units) Table 21. Global Penicillin & Streptomycin Sales Market Share by Type (2021-2026) Table 22. Global Penicillin & Streptomycin Sales Market Share by Type (2027-2032) Table 23. Global Penicillin & Streptomycin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Penicillin & Streptomycin Revenue by Type (2021-2026) & (k units) Table 25. Global Penicillin & Streptomycin Revenue by Type (2027-2032) & (k units) Table 26. Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2026) Table 27. Global Penicillin & Streptomycin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Penicillin & Streptomycin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Penicillin & Streptomycin Sales by Application (2021-2026) & (k units) Table 33. Global Penicillin & Streptomycin Sales by Application (2027-2032) & (k units) Table 34. Global Penicillin & Streptomycin Sales Market Share by Application (2021-2026) Table 35. Global Penicillin & Streptomycin Sales Market Share by Application (2027-2032) Table 36. Global Penicillin & Streptomycin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Penicillin & Streptomycin Revenue by Application (2021-2026) & (k units) Table 38. Global Penicillin & Streptomycin Revenue by Application (2027-2032) & (k units) Table 39. Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2026) Table 40. Global Penicillin & Streptomycin Revenue Market Share by Application (2027-2032) Table 41. Global Penicillin & Streptomycin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Penicillin & Streptomycin Sales by Region (2021-2026) & (k units) Table 43. Global Penicillin & Streptomycin Sales Market Share by Region (2021-2026) Table 44. Global Penicillin & Streptomycin Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Penicillin & Streptomycin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 48. North America Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 49. Europe Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 51. Europe Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Penicillin & Streptomycin Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Penicillin & Streptomycin Sales by Country (2027-2032) & (k units) Table 58. Global Penicillin & Streptomycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Penicillin & Streptomycin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Penicillin & Streptomycin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Penicillin & Streptomycin Revenue Market Share by Region (2021-2026) Table 62. Global Penicillin & Streptomycin Revenue Market Share by Region (2027-2032) Table 63. Takeda Pharmaceutical Company Company Information Table 64. Takeda Pharmaceutical Company Business Overview Table 65. Takeda Pharmaceutical Company Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Company Penicillin & Streptomycin Product Portfolio Table 67. Takeda Pharmaceutical Company Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Penicillin & Streptomycin Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Penicillin & Streptomycin Product Portfolio Table 77. Novartis Recent Development Table 78. Merck & Co. Company Information Table 79. Merck & Co. Business Overview Table 80. Merck & Co. Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck & Co. Penicillin & Streptomycin Product Portfolio Table 82. Merck & Co. Recent Development Table 83. Roche Pharmaceuticals Company Information Table 84. Roche Pharmaceuticals Business Overview Table 85. Roche Pharmaceuticals Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Roche Pharmaceuticals Penicillin & Streptomycin Product Portfolio Table 87. Roche Pharmaceuticals Recent Development Table 88. Eli Lilly and Co Company Information Table 89. Eli Lilly and Co Business Overview Table 90. Eli Lilly and Co Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eli Lilly and Co Penicillin & Streptomycin Product Portfolio Table 92. Eli Lilly and Co Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Penicillin & Streptomycin Product Portfolio Table 97. Pfizer Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Penicillin & Streptomycin Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Bayer HealthCare Company Information Table 104. Bayer HealthCare Business Overview Table 105. Bayer HealthCare Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bayer HealthCare Penicillin & Streptomycin Product Portfolio Table 107. Bayer HealthCare Recent Development Table 108. Amgen Company Information Table 109. Amgen Business Overview Table 110. Amgen Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Amgen Penicillin & Streptomycin Product Portfolio Table 112. Amgen Recent Development Table 113. Astra Zeneca Company Information Table 114. Astra Zeneca Business Overview Table 115. Astra Zeneca Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Astra Zeneca Penicillin & Streptomycin Product Portfolio Table 117. Astra Zeneca Recent Development Table 118. Toyama Chemical Company Information Table 119. Toyama Chemical Business Overview Table 120. Toyama Chemical Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Toyama Chemical Penicillin & Streptomycin Product Portfolio Table 122. Toyama Chemical Recent Development Table 123. Sanofi Aventis Company Information Table 124. Sanofi Aventis Business Overview Table 125. Sanofi Aventis Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Sanofi Aventis Penicillin & Streptomycin Product Portfolio Table 127. Sanofi Aventis Recent Development Table 128. MiddleBrook Pharmaceuticals Company Information Table 129. MiddleBrook Pharmaceuticals Business Overview Table 130. MiddleBrook Pharmaceuticals Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. MiddleBrook Pharmaceuticals Penicillin & Streptomycin Product Portfolio Table 132. MiddleBrook Pharmaceuticals Recent Development Table 133. Gilead Sciences Company Information Table 134. Gilead Sciences Business Overview Table 135. Gilead Sciences Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Gilead Sciences Penicillin & Streptomycin Product Portfolio Table 137. Gilead Sciences Recent Development Table 138. Celgine Corporation Company Information Table 139. Celgine Corporation Business Overview Table 140. Celgine Corporation Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Celgine Corporation Penicillin & Streptomycin Product Portfolio Table 142. Celgine Corporation Recent Development Table 143. Bristol Myers Squibb Company Information Table 144. Bristol Myers Squibb Business Overview Table 145. Bristol Myers Squibb Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Bristol Myers Squibb Penicillin & Streptomycin Product Portfolio Table 147. Bristol Myers Squibb Recent Development Table 148. Biogen IDEC Company Information Table 149. Biogen IDEC Business Overview Table 150. Biogen IDEC Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Biogen IDEC Penicillin & Streptomycin Product Portfolio Table 152. Biogen IDEC Recent Development Table 153. Astellas Pharma Company Information Table 154. Astellas Pharma Business Overview Table 155. Astellas Pharma Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Astellas Pharma Penicillin & Streptomycin Product Portfolio Table 157. Astellas Pharma Recent Development Table 158. Abbot Laboratories Company Information Table 159. Abbot Laboratories Business Overview Table 160. Abbot Laboratories Penicillin & Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Abbot Laboratories Penicillin & Streptomycin Product Portfolio Table 162. Abbot Laboratories Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Penicillin & Streptomycin Distributors List Table 166. Penicillin & Streptomycin Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Penicillin & Streptomycin Product Image Figure 2. Global Penicillin & Streptomycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin & Streptomycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Penicillin & Streptomycin Sales (2021-2032) & (k units) Figure 5. Global Penicillin & Streptomycin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Penicillin & Streptomycin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Penicillin Image Figure 9. Streptomycin Image Figure 10. Global Penicillin & Streptomycin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Penicillin & Streptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Penicillin & Streptomycin Sales Market Share by Type (2021-2032) Figure 13. Global Penicillin & Streptomycin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Penicillin & Streptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Penicillin & Streptomycin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Penicillin & Streptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Penicillin & Streptomycin Sales Market Share by Application (2021-2032) Figure 22. Global Penicillin & Streptomycin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Penicillin & Streptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2032) Figure 25. North America Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 27. U.S. Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 32. Germany Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 39. China Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Penicillin & Streptomycin Sales Market Share by Country (2021-2032) Figure 47. Brazil Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Penicillin & Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Penicillin & Streptomycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Penicillin & Streptomycin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Penicillin & Streptomycin Revenue (2021-2032) & (US$ Million) Figure 58. North America Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Penicillin & Streptomycin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Penicillin & Streptomycin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Penicillin & Streptomycin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Penicillin & Streptomycin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Penicillin & Streptomycin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Streptomycin
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche Pharmaceuticals
  • Eli Lilly and Co
  • Pfizer
  • GlaxoSmithKline
  • Bayer HealthCare
  • Amgen
  • Astra Zeneca
  • Toyama Chemical
  • Sanofi Aventis
  • MiddleBrook Pharmaceuticals
  • Gilead Sciences
  • Celgine Corporation
  • Bristol Myers Squibb
  • Biogen IDEC
  • Astellas Pharma
  • Abbot Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Penicillin & Streptomycin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Penicillin & Streptomycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Penicillin & Streptomycin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Penicillin & Streptomycin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Penicillin & Streptomycin Market Dynamics
  1. 2.1 Penicillin & Streptomycin Industry Trends
  2. 2.2 Penicillin & Streptomycin Industry Drivers
  3. 2.3 Penicillin & Streptomycin Industry Opportunities and Challenges
  4. 2.4 Penicillin & Streptomycin Industry Restraints
3 Penicillin & Streptomycin Market by Manufacturers
  1. 3.1 Global Penicillin & Streptomycin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Penicillin & Streptomycin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Penicillin & Streptomycin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Penicillin & Streptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Penicillin & Streptomycin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Penicillin & Streptomycin Manufacturers, Product Type & Application
  7. 3.7 Global Penicillin & Streptomycin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Penicillin & Streptomycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Penicillin & Streptomycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Penicillin & Streptomycin Tier 1, Tier 2, and Tier 3
4 Penicillin & Streptomycin Market by Type
  1. 4.1 Penicillin & Streptomycin Type Introduction
  2. 4.1.1 Penicillin
  3. 4.1.2 Streptomycin
  4. 4.2 Global Penicillin & Streptomycin Sales by Type
  5. 4.2.1 Global Penicillin & Streptomycin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Penicillin & Streptomycin Sales by Type (2021-2032)
  7. 4.2.3 Global Penicillin & Streptomycin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Penicillin & Streptomycin Revenue by Type
  9. 4.3.1 Global Penicillin & Streptomycin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Penicillin & Streptomycin Revenue by Type (2021-2032)
  11. 4.3.3 Global Penicillin & Streptomycin Revenue Market Share by Type (2021-2032)
5 Penicillin & Streptomycin Market by Application
  1. 5.1 Penicillin & Streptomycin Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Penicillin & Streptomycin Sales by Application
  6. 5.2.1 Global Penicillin & Streptomycin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Penicillin & Streptomycin Sales by Application (2021-2032)
  8. 5.2.3 Global Penicillin & Streptomycin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Penicillin & Streptomycin Revenue by Application
  10. 5.3.1 Global Penicillin & Streptomycin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Penicillin & Streptomycin Revenue by Application (2021-2032)
  12. 5.3.3 Global Penicillin & Streptomycin Revenue Market Share by Application (2021-2032)
6 Global Penicillin & Streptomycin Sales by Region
  1. 6.1 Global Penicillin & Streptomycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Penicillin & Streptomycin Sales by Region (2021-2032)
  3. 6.2.1 Global Penicillin & Streptomycin Sales by Region (2021-2026)
  4. 6.2.2 Global Penicillin & Streptomycin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Penicillin & Streptomycin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Penicillin & Streptomycin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Penicillin & Streptomycin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Penicillin & Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Penicillin & Streptomycin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Penicillin & Streptomycin Revenue by Region
  1. 7.1 Global Penicillin & Streptomycin Revenue by Region
  2. 7.1.1 Global Penicillin & Streptomycin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Penicillin & Streptomycin Revenue by Region (2021-2026)
  4. 7.1.3 Global Penicillin & Streptomycin Revenue by Region (2027-2032)
  5. 7.1.4 Global Penicillin & Streptomycin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Penicillin & Streptomycin Revenue (2021-2032)
  8. 7.2.2 North America Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Penicillin & Streptomycin Revenue (2021-2032)
  11. 7.3.2 Europe Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Penicillin & Streptomycin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Penicillin & Streptomycin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Penicillin & Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company
  2. 8.1.1 Takeda Pharmaceutical Company Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Penicillin & Streptomycin Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Penicillin & Streptomycin Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Penicillin & Streptomycin Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck & Co.
  20. 8.4.1 Merck & Co. Company Information
  21. 8.4.2 Merck & Co. Business Overview
  22. 8.4.3 Merck & Co. Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co. Penicillin & Streptomycin Product Portfolio
  24. 8.4.5 Merck & Co. Recent Developments
  25. 8.5 Roche Pharmaceuticals
  26. 8.5.1 Roche Pharmaceuticals Company Information
  27. 8.5.2 Roche Pharmaceuticals Business Overview
  28. 8.5.3 Roche Pharmaceuticals Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Pharmaceuticals Penicillin & Streptomycin Product Portfolio
  30. 8.5.5 Roche Pharmaceuticals Recent Developments
  31. 8.6 Eli Lilly and Co
  32. 8.6.1 Eli Lilly and Co Company Information
  33. 8.6.2 Eli Lilly and Co Business Overview
  34. 8.6.3 Eli Lilly and Co Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly and Co Penicillin & Streptomycin Product Portfolio
  36. 8.6.5 Eli Lilly and Co Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Penicillin & Streptomycin Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Penicillin & Streptomycin Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Bayer HealthCare
  50. 8.9.1 Bayer HealthCare Company Information
  51. 8.9.2 Bayer HealthCare Business Overview
  52. 8.9.3 Bayer HealthCare Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer HealthCare Penicillin & Streptomycin Product Portfolio
  54. 8.9.5 Bayer HealthCare Recent Developments
  55. 8.10 Amgen
  56. 8.10.1 Amgen Company Information
  57. 8.10.2 Amgen Business Overview
  58. 8.10.3 Amgen Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amgen Penicillin & Streptomycin Product Portfolio
  60. 8.10.5 Amgen Recent Developments
  61. 8.11 Astra Zeneca
  62. 8.11.1 Astra Zeneca Company Information
  63. 8.11.2 Astra Zeneca Business Overview
  64. 8.11.3 Astra Zeneca Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Astra Zeneca Penicillin & Streptomycin Product Portfolio
  66. 8.11.5 Astra Zeneca Recent Developments
  67. 8.12 Toyama Chemical
  68. 8.12.1 Toyama Chemical Company Information
  69. 8.12.2 Toyama Chemical Business Overview
  70. 8.12.3 Toyama Chemical Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Toyama Chemical Penicillin & Streptomycin Product Portfolio
  72. 8.12.5 Toyama Chemical Recent Developments
  73. 8.13 Sanofi Aventis
  74. 8.13.1 Sanofi Aventis Company Information
  75. 8.13.2 Sanofi Aventis Business Overview
  76. 8.13.3 Sanofi Aventis Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sanofi Aventis Penicillin & Streptomycin Product Portfolio
  78. 8.13.5 Sanofi Aventis Recent Developments
  79. 8.14 MiddleBrook Pharmaceuticals
  80. 8.14.1 MiddleBrook Pharmaceuticals Company Information
  81. 8.14.2 MiddleBrook Pharmaceuticals Business Overview
  82. 8.14.3 MiddleBrook Pharmaceuticals Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MiddleBrook Pharmaceuticals Penicillin & Streptomycin Product Portfolio
  84. 8.14.5 MiddleBrook Pharmaceuticals Recent Developments
  85. 8.15 Gilead Sciences
  86. 8.15.1 Gilead Sciences Company Information
  87. 8.15.2 Gilead Sciences Business Overview
  88. 8.15.3 Gilead Sciences Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Gilead Sciences Penicillin & Streptomycin Product Portfolio
  90. 8.15.5 Gilead Sciences Recent Developments
  91. 8.16 Celgine Corporation
  92. 8.16.1 Celgine Corporation Company Information
  93. 8.16.2 Celgine Corporation Business Overview
  94. 8.16.3 Celgine Corporation Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Celgine Corporation Penicillin & Streptomycin Product Portfolio
  96. 8.16.5 Celgine Corporation Recent Developments
  97. 8.17 Bristol Myers Squibb
  98. 8.17.1 Bristol Myers Squibb Company Information
  99. 8.17.2 Bristol Myers Squibb Business Overview
  100. 8.17.3 Bristol Myers Squibb Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bristol Myers Squibb Penicillin & Streptomycin Product Portfolio
  102. 8.17.5 Bristol Myers Squibb Recent Developments
  103. 8.18 Biogen IDEC
  104. 8.18.1 Biogen IDEC Company Information
  105. 8.18.2 Biogen IDEC Business Overview
  106. 8.18.3 Biogen IDEC Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Biogen IDEC Penicillin & Streptomycin Product Portfolio
  108. 8.18.5 Biogen IDEC Recent Developments
  109. 8.19 Astellas Pharma
  110. 8.19.1 Astellas Pharma Company Information
  111. 8.19.2 Astellas Pharma Business Overview
  112. 8.19.3 Astellas Pharma Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Astellas Pharma Penicillin & Streptomycin Product Portfolio
  114. 8.19.5 Astellas Pharma Recent Developments
  115. 8.20 Abbot Laboratories
  116. 8.20.1 Abbot Laboratories Company Information
  117. 8.20.2 Abbot Laboratories Business Overview
  118. 8.20.3 Abbot Laboratories Penicillin & Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Abbot Laboratories Penicillin & Streptomycin Product Portfolio
  120. 8.20.5 Abbot Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Penicillin & Streptomycin Value Chain Analysis
  2. 9.1.1 Penicillin & Streptomycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Penicillin & Streptomycin Production Mode & Process
  6. 9.2 Penicillin & Streptomycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Penicillin & Streptomycin Distributors
  9. 9.2.3 Penicillin & Streptomycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst